These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2723896)

  • 21. Sleep-disordered Breathing and Incident Heart Failure in Older Men.
    Javaheri S; Blackwell T; Ancoli-Israel S; Ensrud KE; Stone KL; Redline S;
    Am J Respir Crit Care Med; 2016 Mar; 193(5):561-8. PubMed ID: 26502092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of Cheyne-Stokes respiration--a mechanism of ventilatory control and the effect of acetazolamide].
    Tojima H; Cho K; Okita S; Kunitomo F; Yuguchi Y; Kuriyama T; Watanabe S; Honda Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Oct; 24(10):1135-41. PubMed ID: 3820880
    [No Abstract]   [Full Text] [Related]  

  • 23. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000075. PubMed ID: 10796115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of apnoea in preterm infants.
    Ruggins NR
    Arch Dis Child; 1991 Jan; 66(1 Spec No):70-3. PubMed ID: 1996899
    [No Abstract]   [Full Text] [Related]  

  • 25. Cheyne-Stokes respiration: Implications for anaesthesiologists.
    Ariès P; Danguy des Déserts M; Nguyen BV; Ould-Ahmed M
    Anaesth Crit Care Pain Med; 2017 Aug; 36(4):245-246. PubMed ID: 27890850
    [No Abstract]   [Full Text] [Related]  

  • 26. Summary proceedings from the apnea-of-prematurity group.
    Finer NN; Higgins R; Kattwinkel J; Martin RJ
    Pediatrics; 2006 Mar; 117(3 Pt 2):S47-51. PubMed ID: 16777822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Apnea in premature infants. Current therapy (author's transl)].
    Saint Martin J
    Ann Pediatr (Paris); 1981 Dec; 28(10):705-8. PubMed ID: 7325533
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of naltrexone on apnea of prematurity and on plasma beta-endorphin-like immunoreactivity.
    MacDonald MG; Moss IR; Kefale GG; Ginzburg HM; Fink RJ; Chin L
    Dev Pharmacol Ther; 1986; 9(5):301-9. PubMed ID: 2946562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theophylline therapy for near-fatal Cheyne-Stokes respiration. A case report.
    Pesek CA; Cooley R; Narkiewicz K; Dyken M; Weintraub NL; Somers VK
    Ann Intern Med; 1999 Mar; 130(5):427-30. PubMed ID: 10068417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylxanthine use for apnea of prematurity among an international cohort of neonatologists.
    Abu Jawdeh EG; O'Riordan M; Limrungsikul A; Bandyopadhyay A; Argus BM; Nakad PE; Supapannachart S; Yunis KA; Davis PG; Martin RJ
    J Neonatal Perinatal Med; 2013; 6(3):251-6. PubMed ID: 24246598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upper airway occlusion during sleep in patients with Cheyne-Stokes respiration.
    Alex CG; Onal E; Lopata M
    Am Rev Respir Dis; 1986 Jan; 133(1):42-5. PubMed ID: 3079976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of patients with central sleep apnea. With and without Cheyne-Stokes respiration.
    Ancoli-Israel S; Engler RL; Friedman PJ; Klauber MR; Ross PA; Kripke DF
    Chest; 1994 Sep; 106(3):780-6. PubMed ID: 8082359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamics, cerebral circulation, and oxygen saturation in Cheyne-Stokes respiration.
    Franklin KA; Sandström E; Johansson G; Bâlfors EM
    J Appl Physiol (1985); 1997 Oct; 83(4):1184-91. PubMed ID: 9338427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theophylline improves pneumogram abnormalities in infants at risk for sudden infant death syndrome.
    Hunt CE; Brouillette RT; Hanson D
    J Pediatr; 1983 Dec; 103(6):969-74. PubMed ID: 6644438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity.
    Lemyre B; Davis PG; De Paoli AG
    Cochrane Database Syst Rev; 2000; (3):CD002272. PubMed ID: 10908544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation of theophylline to caffeine in premature infants.
    Boutroy MJ; Vert P; Monin P; Royer RJ; Royer-Morrot MJ
    Lancet; 1979 Apr; 1(8120):830. PubMed ID: 86080
    [No Abstract]   [Full Text] [Related]  

  • 37. Early childhood developmental follow-up of infants with GMH/IVH: effect of methylxanthine therapy.
    Ment LR; Scott DT; Ehrenkranz RA; Duncan CC
    Am J Perinatol; 1985 Jul; 2(3):223-7. PubMed ID: 4015773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial.
    Schmidt B
    Biol Neonate; 2005; 88(3):208-13. PubMed ID: 16210843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recommended treatment of apnea in premature infants. A review based on literature and own experience].
    Bober K; Swietliński J; Musialik-Swietlińska E; Kornacka MK; Rutkowska M; Rawicz M
    Med Wieku Rozwoj; 2008; 12(4 Pt 1):846-50. PubMed ID: 19471054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental outcome of premature infants treated with theophylline.
    Nelson RM; Resnick MB; Holstrum WJ; Eitzman DV
    Dev Pharmacol Ther; 1980; 1(5):274-80. PubMed ID: 7438973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.